Evidence map›Paper›PMID 37426941›Full record

ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2023

Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies.

Stefania Ruggieri, Maurizio Guido, Chiara Taccaliti, Giuseppe Latorre, Francesca Gallini, Vincenzo Forziati, Domenico Caringella, Alessandra Giocolano, Ilaria Fantasia

Open access · goldAbstract read
In one paragraph

Article in European journal of obstetrics & gynecology and reproductive biology: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Stefania RuggieriDepartment of Obstetrics and Gynecology, General Regional Hospital "F. Miulli", Acquaviva delle Fonti 70021, Italy.
Maurizio GuidoObstetrics & Gynaecology Unit, San Salvatore Hospital, L'Aquila 67100, Italy.
Chiara TaccalitiDepartment of Obstetrics and Gynecology, Civitanova Marche Hospital, Civitanova Marche 62012, Italy.
Giuseppe LatorreNeonatology Unit, General Regional Hospital "F. Miulli", Acquaviva delle Fonti 70021, Italy.
Francesca GalliniNeonatology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome 00168, Italy.
Vincenzo ForziatiNeonatology Unit, General Regional Hospital "F. Miulli", Acquaviva delle Fonti 70021, Italy.
Domenico CaringellaDepartment of Obstetrics and Gynecology, General Regional Hospital "F. Miulli", Acquaviva delle Fonti 70021, Italy.
Alessandra GiocolanoDepartment of Obstetrics and Gynecology, General Regional Hospital "F. Miulli", Acquaviva delle Fonti 70021, Italy.
Ilaria FantasiaObstetrics & Gynaecology Unit, San Salvatore Hospital, L'Aquila 67100, Italy.
Ospedale Generale Regionale Francesco Miulli · ITAgostino Gemelli University Polyclinic · ITL'organizzazione Ospedale di Civitanova M · ITSan Salvatore Hospital · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare obstetrical and neonatal outcomes in patients with p-PROM (preterm premature rupture of membranes) at less than 30 weeks of gestational age before and after the application of protocols developed on the basis of international guidelines and to identify local barriers and strategies for their implementation. Study design: Single and twin pregnancies with p-PROM < 30 weeks of gestation without signs of infection were retrospectively collected. The population was divided in two groups. Group A contained patients treated before the introduction of the protocol, hospitalized from the day of the p-PROM to delivery and treated according to clinicians' practice. Group B included patients managed according to a standardized protocol, treated with home care management under strict surveillance, after 48 h of hospitalization. Results: 19 women with 21 newborns in group A and 22 women with 26 newborns in group B were enrolled. Maternal characteristics and p-PROM gestational age were comparable. In group A we observed minor latency time from diagnosis to delivery (1.6 vs 6.5 weeks, p < 0.001) with lower gestational age at delivery (25.8 ± 2 vs 30.7 ± 4.2 weeks, p = 0.00) and lower newborn weight (859 ± 268 vs 1511 ± 917 g, p = 0.002). Concerning neonatal outcomes, in group A there were lower Apgar score at 1 min (4.0 ± 2.1vs 6.3 ± 2, p = 004), longer hospitalization (42 ± 38 vs 68 ± 38 days, p = 0.05) and, even if non statistically significant, major rate of neonatal mortality (11,5% vs 19%, p = 1.00) and of neonatal complications (need of neonatal intensive care unit, sepsis, bronchopulmonary dysplasia, retinopathy of prematurity, mechanical ventilation). Postnatal follow-up showed comparable outcomes at 24 months of correct age. Conclusions: Educational and interdisciplinary meetings, along with group performance audit and standardization of procedures are successful strategies to implement guidelines application. Applying this strategy, we developed a protocol according to international guidelines for the treatment of early onset p-PROM based on a standardized conservative management at home, achieving better results compared to hospital management in terms of latency, gestational age at delivery, neonatal weight and neonatal hospitalization.

Indexed as

Conservative managementGuidelinesHome careImplementation strategiesPreterm premature rupture of membranes

Identifiers

PMID37426941
PMCPMC10329107
OpenAlexW4380987100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.